| 摘要 |
FIELD: medicine.SUBSTANCE: claimed group of inventions relates to medicine, namely to neurology, and deals with application of 4-aminopyridine for improving condition in case of neurocognitive and/or neuropsychiatric disorder in patients with multiple sclerosis. For this purpose effective quantity of composition with delayed release, containing 4-aminopyridine, is introduced.EFFECT: invention provides reduction of such cognitive disorders as attention span, impaired memory and fluency, etc in patients with multiple sclerosis.35 cl, 3 dwg, 2 ex |
